glp 1 abbreviation medical GLP-1 Medications Infographic GLP-1 and GIP in Type

We discuss adverse events of specific interest observed with these therapies (and their potential underlying mechanisms), including GI side effects, psychiatric, ocular, thyroid, biliary, and pancreatic complications (Table 1)

Medications that influence the whole body demand continuous oversight

In 2025, the GLP-1 receptor agonist market was valued at $66.4 billion and is projected to grow to $82 billion in 2026

These drugs are primarily approved for treating type 2 diabetes, so coverage is usually only available if a patient with PCOS also has type 2 diabetes or obesity as a related condition

Moreover, GLP-2 injection reduced CD4(+) T cell population

Serious side effects are rare but should be reported to your provider immediately for review and possible treatment adjustments